# Biotech Daily Digest ‚Äî 2025-10-21

**48 items from 3 sources**

## Summary by Source

- Endpoints News: 10 items
- Fierce Biotech: 6 items
- arXiv q-bio: 32 items


## Endpoints News

- **[Chemify raises $50M+ Series B to scale molecule-making business](https://endpoints.news/chemify-raises-50m-series-b-to-scale-molecule-making-business/)**  
  _Tue, 21 Oct 2025 12:00:17 +0000_  
  In Glasgow, Scotland, Lee Cronin is betting his startup can make molecules better than the low-cost competition in India and China.

 Chemify has just raised $50 million in a Series B to scale up what ...

- **[CRISPR Therapeutics says its new gene editing tool is 'a significant advance' over prime editing. Prime Medicine disagrees](https://endpoints.news/crispr-therapeutics-says-its-new-gene-editing-tool-is-a-significant-advance-over-prime-editing-prime-medicine-disagrees/)**  
  _Tue, 21 Oct 2025 11:00:14 +0000_  
  Breaking things is easier than fixing them, and so far, CRISPR Therapeutics has been largely focused on using its molecular scissors to shut down the production of problematic genes.
 But the company is now gearing ...

- **[Galapagos to exit cell therapy, with loss of 365 jobs and global sites to shutter](https://endpoints.news/galapagos-to-exit-cell-therapy-with-loss-of-365-jobs-and-global-sites-to-shutter/)**  
  _Tue, 21 Oct 2025 10:56:09 +0000_  
  

- **['Decade of the ADCs' continues as AstraZeneca, Kelun and Merck present data at #ESMO25](https://endpoints.news/decade-of-the-adcs-continues-as-astrazeneca-kelun-and-merck-present-data-at-esmo25/)**  
  _Tue, 21 Oct 2025 09:15:27 +0000_  
  Two years ago at the European Society for Medical Oncology‚Äôs annual meeting, a prominent oncologist predicted that the 2020s would be the ‚Äúdecade of the ADCs.‚Äù

 There were several high-value ADC-focused deals ...

- **[Replimune resubmits melanoma drug for FDA approval](https://endpoints.news/replimune-resubmits-melanoma-drug-for-fda-approval/)**  
  _Mon, 20 Oct 2025 19:31:08 +0000_  
  Cancer biotech Replimune has resubmitted its melanoma drug for FDA approval after the agency's rejection earlier this summer raised questions about its path forward.

 The company said Monday that the FDA ...

- **[Summit plans to take ivonescimab to FDA, even with subpar OS data](https://endpoints.news/summit-plans-to-take-ivonescimab-to-fda-even-with-subpar-os-data/)**  
  _Mon, 20 Oct 2025 19:05:12 +0000_  
  Summit Therapeutics says it will submit an application to the FDA by the end of the year to review its PD-1xVEGF bispecific antibody, pressing forward with the program despite a mixed Phase 3 readout last ...

- **[Three drugs push CBO to raise orphan cost estimate to $8.8B over 10 years](https://endpoints.news/three-drugs-push-cbo-to-raise-orphan-cost-estimate-to-8-8b-over-10-years/)**  
  _Mon, 20 Oct 2025 18:16:04 +0000_  
  The Congressional Budget Office on Monday almost doubled its cost estimate for new orphan drug protections granted under President Donald Trump‚Äôs recently-enacted tax package after finding that the law will impact price negotiations for three ...

- **[Celcuity‚Äôs shares rally after ESMO readouts; Disc Medicine‚Äôs $220M stock sale](https://endpoints.news/celcuitys-shares-rally-after-esmo-readouts-disc-medicines-220m-stock-sale/)**  
  _Mon, 20 Oct 2025 15:24:27 +0000_  
  Plus, news about Novo Nordisk, Amgen, AstraZeneca, Viridian Therapeutics, Alto Neuroscience and Siren Biotechnology:

 üìà Celcuity‚Äôs stock soars after ESMO readouts in breast cancer: After Roche presented its #ESMO25 readout for giredestrant ...

- **[#ESMO25: Roche says ctDNA-guided Tecentriq prolonged survival in bladder cancer patients](https://endpoints.news/esmo25-roche-says-ctdna-guided-tecentriq-prolonged-survival-in-bladder-cancer-patients/)**  
  _Mon, 20 Oct 2025 15:10:59 +0000_  
  BERLIN ‚Äî Roche presented Phase 3 data showing that adjuvant Tecentriq benefited a subset of bladder cancer patients who were deemed a higher risk for recurrence based on a blood test.  ...

- **[RAPT, Jeyou are itching to start Phase 3 after encouraging mid-stage results in urticaria](https://endpoints.news/rapt-jeyou-are-itching-to-start-phase-3-after-encouraging-mid-stage-results-in-urticaria/)**  
  _Mon, 20 Oct 2025 15:04:55 +0000_  
  RAPT Therapeutics' partner Shanghai Jeyou Pharmaceutical intends to put the itch therapy that they are developing into late-stage trials following a positive showing in Phase 2.

 The China-based trial conducted by Jeyou assessed the anti ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/galapagos-wind-down-cell-therapy-unit-threatening-365-jobs-and-5-facilities" hreflang="en">Galapagos to wind down cell therapy unit, threatening 365 jobs and 5 facilities</a>](https://www.fiercebiotech.com/biotech/galapagos-wind-down-cell-therapy-unit-threatening-365-jobs-and-5-facilities)**  
  _Oct 21, 2025 9:10am_  
  Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months.

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025" hreflang="en">Fierce Biotech Layoff Tracker 2025: Galapagos shutters cell therapy unit; Kezar plots cuts</a>](https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025)**  
  _Dec 23, 2024 11:52am_  
  As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.

- **[<a href="https://www.fiercebiotech.com/medtech/science-corps-retinal-implant-restores-some-vision-patients-macular-degeneration" hreflang="en">Science Corp.'s retinal implant restores some vision in patients with macular degeneration</a>](https://www.fiercebiotech.com/medtech/science-corps-retinal-implant-restores-some-vision-patients-macular-degeneration)**  
  _Oct 21, 2025 2:41am_  
  A retinal implant developed by Science Corp. has for the first time restored some functional vision to patients with a severe form of age-related macular degeneration, a common eye disease and the leading cause of blindness, according to a new study.

- **[<a href="https://www.fiercebiotech.com/biotech/esmo-adc-rollercoaster-rides" hreflang="en">ESMO: The ADC 'rollercoaster' rides on with new generation of therapies</a>](https://www.fiercebiotech.com/biotech/esmo-adc-rollercoaster-rides)**  
  _Oct 19, 2025 10:03am_  
  From Roche‚Äôs $1.4 billion licensing deal to AstraZeneca‚Äôs presidential symposium and an avalanche of clinical readouts, antibody-drug conjugates dominated Europe‚Äôs leading cancer conference over the weekend.

- **[<a href="https://www.fiercebiotech.com/pharma/merck-grows-more-ambitious-about-workhorse-trop2-adc-partner-kelun-posts-phase-3-wins" hreflang="en">Merck grows more ambitious about 'workhorse' TROP2 ADC as partner Kelun posts phase 3 wins</a>](https://www.fiercebiotech.com/pharma/merck-grows-more-ambitious-about-workhorse-trop2-adc-partner-kelun-posts-phase-3-wins)**  
  _Oct 20, 2025 2:07pm_  
  Merck has just registered the 15th global phase 3 trial for its TROP2 antibody-drug conjugate, sac-TMT, just as its Chinese partner Kelun-Biotech reported two sets of strong phase 3 results in patients with lung cancer and breast cancer.

- **[<a href="https://www.fiercebiotech.com/biotech/esmo-daiichi-merck-power-ovarian-cancer-adc-toward-pivotal-trial-after-passing-phase-2-test" hreflang="en">ESMO: Daiichi, Merck power ovarian cancer ADC toward pivotal test after passing phase 2</a>](https://www.fiercebiotech.com/biotech/esmo-daiichi-merck-power-ovarian-cancer-adc-toward-pivotal-trial-after-passing-phase-2-test)**  
  _Oct 20, 2025 10:26am_  
  Daiichi Sankyo and Merck & Co. have reported midphase ovarian cancer data, clearing the partners to advance the antibody-drug conjugate into the phase 3 part of the trial.


## arXiv q-bio

- **[Hallucinations in AlphaFold3 for Intrinsically Disordered Proteins with disorder in Biological Process Residues](https://arxiv.org/abs/2510.15939)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.15939v1 Announce Type: new 
Abstract: Protein structure prediction has advanced significantly with the introduction of AlphaFold3, a diffusion-based model capable of predicting complex biomolecular interactions across proteins, nucleic acids, small molecules, and ions. While AlphaFold3 demonstrates high acc‚Ä¶

- **[AGNES: Adaptive Graph Neural Network and Dynamic Programming Hybrid Framework for Real-Time Nanopore Seed Chaining](https://arxiv.org/abs/2510.16013)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16013v1 Announce Type: new 
Abstract: Nanopore sequencing enables real-time long-read DNA sequencing with reads exceeding 10 kilobases, but inherent error rates of 12-15 percent present significant computational challenges for read alignment. The critical seed chaining step must connect exact k-mer matches‚Ä¶

- **[TriAgent: Automated Biomarker Discovery with Deep Research Grounding for Triage in Acute Care by LLM-Based Multi-Agent Collaboration](https://arxiv.org/abs/2510.16080)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16080v1 Announce Type: new 
Abstract: Emergency departments worldwide face rising patient volumes, workforce shortages, and variability in triage decisions that threaten the delivery of timely and accurate care. Current triage methods rely primarily on vital signs, routine laboratory values, and clinicians'‚Ä¶

- **[Interpretable RNA-Seq Clustering with an LLM-Based Agentic Evidence-Grounded Framework](https://arxiv.org/abs/2510.16082)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16082v1 Announce Type: new 
Abstract: We propose CITE V.1, an agentic, evidence-grounded framework that leverages Large Language Models (LLMs) to provide transparent and reproducible interpretations of RNA-seq clusters. Unlike existing enrichment-based approaches that reduce results to broad statistical ass‚Ä¶

- **[Identifying multi-omics interactions for lung cancer drug targets discovery using Kernel Machine Regression](https://arxiv.org/abs/2510.16093)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16093v1 Announce Type: new 
Abstract: Cancer exhibits diverse and complex phenotypes driven by multifaceted molecular interactions. Recent biomedical research has emphasized the comprehensive study of such diseases by integrating multi-omics datasets (genome, proteome, transcriptome, epigenome). This approa‚Ä¶

- **[BASIN: Bayesian mAtrix variate normal model with Spatial and sparsIty priors in Non-negative deconvolution](https://arxiv.org/abs/2510.16130)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16130v1 Announce Type: new 
Abstract: Spatial transcriptomics allows researchers to visualize and analyze gene expression within the precise location of tissues or cells. It provides spatially resolved gene expression data but often lacks cellular resolution, necessitating cell type deconvolution to infer c‚Ä¶

- **[Topological decoding of grid cell activity via path lifting to covering spaces](https://arxiv.org/abs/2510.16216)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16216v1 Announce Type: new 
Abstract: High-dimensional neural activity often reside in a low-dimensional subspace, referred to as neural manifolds. Grid cells in the medial entorhinal cortex provide a periodic spatial code that are organized near a toroidal manifold, independent of the spatial environment.‚Ä¶

- **[Vertical Ground Reaction Forces Waveform Flattening during Gait in Women with Knee Osteoarthritis](https://arxiv.org/abs/2510.16942)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16942v1 Announce Type: new 
Abstract: Background. Knee Osteoarthritis (OA) is a common chronic joint condition, and its prevalence increases with age. This study aims to examine whether flattened vertical ground reaction force (vGRF) waveforms and reduced knee range of motion (RoM) occur together during gai‚Ä¶

- **[Ambush strategy impacts species predominance and coexistence in rock-paper-scissors models](https://arxiv.org/abs/2510.17016)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.17016v1 Announce Type: new 
Abstract: We investigate the adaptive Ambush strategy in cyclic models following the rules of the spatial rock-paper-scissors game. In our model, individuals of one species possess cognitive abilities to perceive environmental cues and assess the local density of the species they‚Ä¶

- **[A Minimal Quantitative Model of Perceptual Suppression and Breakthrough in Visual Rivalry](https://arxiv.org/abs/2510.17154)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.17154v1 Announce Type: new 
Abstract: When conflicting images are presented to either eye, binocular fusion is disrupted. Rather than experiencing a blend of both percepts, often only one eye's image is experienced, whilst the other is suppressed from awareness. Importantly, suppression is transient - the t‚Ä¶

- **[A Tractography Analysis Framework Using Diffusion Maps to Study Thalamic Connectivity in Traumatic Brain Injury](https://arxiv.org/abs/2510.17273)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.17273v1 Announce Type: new 
Abstract: Traumatic brain injury (TBI) disrupts thalamocortical connectivity, contributing to cognitive impairment and post-traumatic epilepsy (PTE). This study presents a novel tractography-based framework that leverages diffusion maps to capture microstructural and organization‚Ä¶

- **[A theory for self-sustained balanced states in absence of strong external currents](https://arxiv.org/abs/2510.17492)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.17492v1 Announce Type: new 
Abstract: Recurrent neural networks with balanced excitation and inhibition exhibit irregular asynchronous dynamics, which is fundamental for cortical computations. Classical balance mechanisms require strong external inputs to sustain finite firing rates, raising concerns about‚Ä¶

- **[Mendelian randomization in a multi-ancestry world: reflections and practical advice](https://arxiv.org/abs/2510.17554)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.17554v1 Announce Type: new 
Abstract: Many Mendelian randomization (MR) papers have been conducted only in people of European ancestry, limiting transportability of results to the global population. Expanding MR to diverse ancestry groups is essential to ensure equitable biomedical insights, yet presents an‚Ä¶

- **[Paradoxical increase of capacity due to spurious overlaps in attractor networks](https://arxiv.org/abs/2510.17593)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.17593v1 Announce Type: new 
Abstract: In Hopfield-type associative memory models, memories are stored in the connectivity matrix and can be retrieved subsequently thanks to the collective dynamics of the network. In these models, the retrieval of a particular memory can be hampered by overlaps between the n‚Ä¶

- **[Generative AI for Biosciences: Emerging Threats and Roadmap to Biosecurity](https://arxiv.org/abs/2510.15975)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.15975v1 Announce Type: cross 
Abstract: The rapid adoption of generative artificial intelligence (GenAI) in the biosciences is transforming biotechnology, medicine, and synthetic biology. Yet this advancement is intrinsically linked to new vulnerabilities, as GenAI lowers the barrier to misuse and introduce‚Ä¶

- **[Protein Folding with Neural Ordinary Differential Equations](https://arxiv.org/abs/2510.16253)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16253v1 Announce Type: cross 
Abstract: Recent advances in protein structure prediction, such as AlphaFold, have demonstrated the power of deep neural architectures like the Evoformer for capturing complex spatial and evolutionary constraints on protein conformation. However, the depth of the Evoformer, com‚Ä¶

- **[Parameter Identifiability of RNA Dynamics in PDE Transport Models of Fluorescence Recovery After Photobleaching](https://arxiv.org/abs/2510.16304)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16304v1 Announce Type: cross 
Abstract: The transport and localization of RNA molecules, crucial for cellular function and development, involve a combination of diffusion and active transport mechanisms. Here, we are motivated by understanding the dynamics of RNA in Xenopus laevis oocytes. Fluorescence Reco‚Ä¶

- **[Quantifying the compressibility of the human brain](https://arxiv.org/abs/2510.16327)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16327v1 Announce Type: cross 
Abstract: In the human brain, the allowed patterns of activity are constrained by the correlations between brain regions. Yet it remains unclear which correlations -- and how many -- are needed to predict large-scale neural activity. Here, we present an information-theoretic fr‚Ä¶

- **[Computer Navigated Spinal Surgery Using Magnetic Resonance Imaging and Augmented Reality](https://arxiv.org/abs/2510.16347)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16347v1 Announce Type: cross 
Abstract: Current spinal pain management procedures, such as radiofrequency ablation (RFA) and epidural steroid injection (ESI), rely on fluoroscopy for needle placement which exposes patients and physicians to ionizing radiation. In this paper, we investigate a radiation-free‚Ä¶

- **[Evaluating protein binding interfaces with PUMBA](https://arxiv.org/abs/2510.16674)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16674v1 Announce Type: cross 
Abstract: Protein-protein docking tools help in studying interactions between proteins, and are essential for drug, vaccine, and therapeutic development. However, the accuracy of a docking tool depends on a robust scoring function that can reliably differentiate between native‚Ä¶

- **[ProtoMol: Enhancing Molecular Property Prediction via Prototype-Guided Multimodal Learning](https://arxiv.org/abs/2510.16824)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.16824v1 Announce Type: cross 
Abstract: Multimodal molecular representation learning, which jointly models molecular graphs and their textual descriptions, enhances predictive accuracy and interpretability by enabling more robust and reliable predictions of drug toxicity, bioactivity, and physicochemical pr‚Ä¶

- **[A Standardized Benchmark for Machine-Learned Molecular Dynamics using Weighted Ensemble Sampling](https://arxiv.org/abs/2510.17187)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2510.17187v1 Announce Type: cross 
Abstract: The rapid evolution of molecular dynamics (MD) methods, including machine-learned dynamics, has outpaced the development of standardized tools for method validation. Objective comparison between simulation approaches is often hindered by inconsistent evaluation metric‚Ä¶

- **[mRNA active transport in oocyte-early embryo: 3D agent-based modeling](https://arxiv.org/abs/2301.05006)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2301.05006v2 Announce Type: replace 
Abstract: Axes of polarity (and primary morphogenetic gradients) are established in the oocyte - early embryo through active transport and localization of maternal factors. It is the oocyte - syncytial embryo of Drosophila (D. melanogaster) that is a model object for studying‚Ä¶

- **[Optimal control of stochastic reaction networks with entropic control cost and emergence of mode-switching strategies](https://arxiv.org/abs/2409.17488)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2409.17488v2 Announce Type: replace 
Abstract: Controlling the stochastic dynamics of biological populations is a challenge that arises across various biological contexts. However, these dynamics are inherently nonlinear and involve a discrete state space, i.e., the number of molecules, cells, or organisms. Addi‚Ä¶

- **[Age-Structured Population Dynamics](https://arxiv.org/abs/2506.03405)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2506.03405v3 Announce Type: replace 
Abstract: This chapter reviews some aspects of the theory of age-structured models of populations with finite maximum age. We formulate both the renewal equation for the birth rate and the partial differential equation for the age density, and show their equivalence. Next, we‚Ä¶

- **[Size-Structured Population Dynamics](https://arxiv.org/abs/2506.03413)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2506.03413v3 Announce Type: replace 
Abstract: This chapter focuses on variable maturation delay or, more precisely, on the mathematical description of a size-structured population consuming an unstructured resource. When the resource concentration is a known function of time, we can describe the growth and surv‚Ä¶

- **[Reshaping Biomolecular Structure Prediction through Strategic Conformational Exploration with HelixFold-S1](https://arxiv.org/abs/2507.09251)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2507.09251v2 Announce Type: replace 
Abstract: Generating large ensembles of candidate conformations is standard for improving biomolecular structure prediction. Yet aimless sampling is inefficient and costly, producing many redundant conformations with limited diversity, so additional computation often yields l‚Ä¶

- **[Transformer-Based Hematological Malignancy Prediction from Peripheral Blood Smears in a Real-World Cohort](https://arxiv.org/abs/2509.20402)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2509.20402v3 Announce Type: replace 
Abstract: Peripheral blood smears remain a cornerstone in the diagnosis of hematological neoplasms, offering rapid and valuable insights that inform subsequent diagnostic steps. However, since neoplastic transformations typically arise in the bone marrow, they may not manifes‚Ä¶

- **[OneProt: Towards Multi-Modal Protein Foundation Models](https://arxiv.org/abs/2411.04863)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2411.04863v3 Announce Type: replace-cross 
Abstract: Recent advances in Artificial Intelligence have enabled multi-modal systems to model and translate diverse information spaces. Extending beyond text and vision, we introduce OneProt, a multi-modal AI for proteins that integrates structural, sequence, text, and‚Ä¶

- **[GeoRecon: Graph-Level Representation Learning for 3D Molecules via Reconstruction-Based Pretraining](https://arxiv.org/abs/2506.13174)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2506.13174v2 Announce Type: replace-cross 
Abstract: The pretraining-finetuning paradigm has powered major advances in domains such as natural language processing and computer vision, with representative examples including masked language modeling and next-token prediction. In molecular representation learning,‚Ä¶

- **[Design and optimization of in situ self-functionalizing stress sensors](https://arxiv.org/abs/2507.05907)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2507.05907v2 Announce Type: replace-cross 
Abstract: Mechanical contributions are crucial regulators of diverse biological processes, yet their \textit{in vivo} measurement remains challenging due to limitations of current techniques, that can be destructive or require complex dedicated setups. This study introd‚Ä¶

- **[FGBench: A Dataset and Benchmark for Molecular Property Reasoning at Functional Group-Level in Large Language Models](https://arxiv.org/abs/2508.01055)**  
  _Tue, 21 Oct 2025 00:00:00 -0400_  
  arXiv:2508.01055v3 Announce Type: replace-cross 
Abstract: Large language models (LLMs) have gained significant attention in chemistry. However, most existing datasets center on molecular-level property prediction and overlook the role of fine-grained functional group (FG) information. Incorporating FG-level data can‚Ä¶
